A Phase II Trial of Abiraterone Acetate, Radiotherapy and Short-Term Androgen Deprivation in Men With Unfavorable Risk Localized Prostate Cancer
Latest Information Update: 14 Feb 2024
At a glance
- Drugs Abiraterone acetate (Primary) ; Goserelin; Leuprorelin; Prednisone
- Indications Prostate cancer
- Focus Proof of concept; Therapeutic Use
- 06 Oct 2022 Status changed from active, no longer recruiting to completed.
- 27 Oct 2021 Planned End Date changed from 1 Aug 2021 to 1 Apr 2022.
- 18 Sep 2017 Planned End Date changed from 1 Sep 2021 to 1 Aug 2021.